

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.78277664 |
| 2 | negative thymic T cell selection (GO:0045060) | 8.02913992 |
| 3 | positive T cell selection (GO:0043368) | 7.75701215 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.59544251 |
| 5 | negative regulation of cell killing (GO:0031342) | 7.40594796 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.40594796 |
| 7 | thymic T cell selection (GO:0045061) | 6.82835027 |
| 8 | T cell selection (GO:0045058) | 6.76375478 |
| 9 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.70724018 |
| 10 | interferon-gamma production (GO:0032609) | 6.24967607 |
| 11 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 6.10049638 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 6.09335743 |
| 13 | response to interleukin-15 (GO:0070672) | 6.08960587 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.06159290 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.91653846 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.91653846 |
| 17 | * T cell receptor signaling pathway (GO:0050852) | 5.81248314 |
| 18 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.59841472 |
| 19 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 5.57667300 |
| 20 | cytidine metabolic process (GO:0046087) | 5.53574520 |
| 21 | cytidine catabolic process (GO:0006216) | 5.53574520 |
| 22 | cytidine deamination (GO:0009972) | 5.53574520 |
| 23 | T cell migration (GO:0072678) | 5.49223376 |
| 24 | leukocyte aggregation (GO:0070486) | 5.48010613 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 5.35189254 |
| 26 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.16857941 |
| 27 | * T cell costimulation (GO:0031295) | 5.16798224 |
| 28 | * lymphocyte costimulation (GO:0031294) | 5.10184580 |
| 29 | activated T cell proliferation (GO:0050798) | 5.04654705 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02057211 |
| 31 | * regulation of gamma-delta T cell activation (GO:0046643) | 5.00930328 |
| 32 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.85872649 |
| 33 | V(D)J recombination (GO:0033151) | 4.82103119 |
| 34 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.78182569 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.58911065 |
| 36 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.54663377 |
| 37 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.50063566 |
| 38 | DNA deamination (GO:0045006) | 4.39275369 |
| 39 | positive regulation of tolerance induction (GO:0002645) | 4.36959466 |
| 40 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.36812374 |
| 41 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.36812374 |
| 42 | negative regulation of T cell apoptotic process (GO:0070233) | 4.35811343 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.30954402 |
| 44 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.27156377 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.27156377 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.27025601 |
| 47 | positive regulation of interleukin-2 production (GO:0032743) | 4.25048738 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 4.23891496 |
| 49 | positive regulation of isotype switching (GO:0045830) | 4.23034717 |
| 50 | mast cell activation (GO:0045576) | 4.16836017 |
| 51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.10415630 |
| 52 | sequestering of actin monomers (GO:0042989) | 4.10258600 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.08560748 |
| 54 | tolerance induction (GO:0002507) | 4.04914981 |
| 55 | * T cell differentiation (GO:0030217) | 3.99745950 |
| 56 | regulation of isotype switching (GO:0045191) | 3.98292855 |
| 57 | alpha-beta T cell differentiation (GO:0046632) | 3.98075830 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.93005766 |
| 59 | alpha-beta T cell activation (GO:0046631) | 3.92254335 |
| 60 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.92011694 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91476278 |
| 62 | * regulation of T cell receptor signaling pathway (GO:0050856) | 3.90139444 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.81868429 |
| 64 | positive regulation of DNA recombination (GO:0045911) | 3.69747535 |
| 65 | regulation of response to interferon-gamma (GO:0060330) | 3.65109337 |
| 66 | lymphocyte chemotaxis (GO:0048247) | 3.64434965 |
| 67 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.63112458 |
| 68 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.62431651 |
| 69 | positive regulation of B cell mediated immunity (GO:0002714) | 3.62431651 |
| 70 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.61947380 |
| 71 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.61273711 |
| 72 | * T cell activation (GO:0042110) | 3.60964908 |
| 73 | positive regulation of humoral immune response (GO:0002922) | 3.58923163 |
| 74 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.57666764 |
| 75 | Peyers patch development (GO:0048541) | 3.56863712 |
| 76 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.56863712 |
| 77 | T cell homeostasis (GO:0043029) | 3.51656484 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.51576260 |
| 79 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.48976494 |
| 80 | regulation of B cell mediated immunity (GO:0002712) | 3.45837314 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40648127 |
| 82 | leukocyte cell-cell adhesion (GO:0007159) | 3.39949019 |
| 83 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.37888511 |
| 84 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.37409168 |
| 85 | regulation of cell killing (GO:0031341) | 3.37205019 |
| 86 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.36837265 |
| 87 | positive regulation of cell killing (GO:0031343) | 3.36781309 |
| 88 | positive regulation of defense response to virus by host (GO:0002230) | 3.33926333 |
| 89 | mast cell activation involved in immune response (GO:0002279) | 3.33618575 |
| 90 | mast cell degranulation (GO:0043303) | 3.33618575 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.32744030 |
| 92 | cellular response to interleukin-4 (GO:0071353) | 3.31938113 |
| 93 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.31548714 |
| 94 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.30666967 |
| 95 | natural killer cell activation (GO:0030101) | 3.29674166 |
| 96 | regulation of interleukin-2 production (GO:0032663) | 3.28603472 |
| 97 | positive regulation of immunoglobulin production (GO:0002639) | 3.28554613 |
| 98 | regulation of immunoglobulin production (GO:0002637) | 3.28552193 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28291815 |
| 100 | immunoglobulin mediated immune response (GO:0016064) | 3.25625029 |
| 101 | type I interferon signaling pathway (GO:0060337) | 3.25527335 |
| 102 | cellular response to type I interferon (GO:0071357) | 3.25527335 |
| 103 | regulation of alpha-beta T cell activation (GO:0046634) | 3.24292801 |
| 104 | positive regulation of interleukin-4 production (GO:0032753) | 3.23917404 |
| 105 | response to type I interferon (GO:0034340) | 3.23546462 |
| 106 | positive regulation of T cell mediated immunity (GO:0002711) | 3.21507351 |
| 107 | * B cell receptor signaling pathway (GO:0050853) | 3.20538186 |
| 108 | regulation of B cell differentiation (GO:0045577) | 3.20395825 |
| 109 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.18807319 |
| 110 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.18690228 |
| 111 | regulation of T cell apoptotic process (GO:0070232) | 3.14892736 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.14439637 |
| 113 | negative regulation of viral genome replication (GO:0045071) | 3.14082047 |
| 114 | heterotypic cell-cell adhesion (GO:0034113) | 3.12874480 |
| 115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12493408 |
| 116 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.12280325 |
| 117 | * positive regulation of T cell activation (GO:0050870) | 3.12082225 |
| 118 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.11888461 |
| 119 | dendritic cell chemotaxis (GO:0002407) | 3.10948919 |
| 120 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.10207246 |
| 121 | leukocyte degranulation (GO:0043299) | 3.09087255 |
| 122 | T-helper cell differentiation (GO:0042093) | 3.08282015 |
| 123 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.08282015 |
| 124 | T cell proliferation (GO:0042098) | 3.07979770 |
| 125 | lymphocyte migration (GO:0072676) | 3.06836939 |
| 126 | regulation of T cell mediated immunity (GO:0002709) | 3.05159196 |
| 127 | positive regulation of granulocyte differentiation (GO:0030854) | 3.04356450 |
| 128 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.01398860 |
| 129 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.01398860 |
| 130 | T cell differentiation involved in immune response (GO:0002292) | 3.01398860 |
| 131 | cellular defense response (GO:0006968) | 2.99903964 |
| 132 | response to interleukin-4 (GO:0070670) | 2.99117192 |
| 133 | regulation of activation of Janus kinase activity (GO:0010533) | 2.97876339 |
| 134 | lymphocyte homeostasis (GO:0002260) | 2.97025902 |
| 135 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.96860327 |
| 136 | actin nucleation (GO:0045010) | 2.93240128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.29394557 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.75728356 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20888492 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68369378 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.61093699 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58008372 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.46615718 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.39269496 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.36877770 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.28680486 |
| 11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.23482475 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.14723168 |
| 13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.82532690 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75309207 |
| 15 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.75195310 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67560701 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.65569131 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53445689 |
| 19 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28887818 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25483756 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.15785216 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12499935 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12453806 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11272617 |
| 25 | * MAF_26560356_Chip-Seq_TH2_Human | 2.05466319 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.04281976 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01321185 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.99763359 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90449327 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87263496 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86464184 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.82881458 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82473172 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73335931 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70354878 |
| 36 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70329013 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69073703 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68172008 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63908313 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60168129 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58955008 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54573364 |
| 43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52860371 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51542372 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51190543 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50955746 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49358454 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49060642 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46442883 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45485030 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42991037 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40884981 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37778838 |
| 54 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30383876 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.25623488 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.24340620 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21014986 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19131759 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19067327 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17248723 |
| 61 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17215013 |
| 62 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16646925 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15498866 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13358847 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13099781 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11806309 |
| 67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11069699 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08251910 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06211106 |
| 70 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04255737 |
| 71 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.03570291 |
| 72 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03121638 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02347853 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01603178 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00544393 |
| 76 | GATA3_26560356_Chip-Seq_TH1_Human | 0.99917138 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97330427 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96875399 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95575020 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95351943 |
| 81 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.95072793 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94891212 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94682065 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94037479 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93402450 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.92852603 |
| 87 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92818735 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92755067 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92633591 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92512887 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92080131 |
| 92 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91864562 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91132503 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.90139027 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88957682 |
| 96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.88159760 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87974333 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87947753 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87356662 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86929669 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86156610 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85465156 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85031342 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84968777 |
| 105 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.83661934 |
| 106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81713249 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.81680996 |
| 108 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80966507 |
| 109 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.79929579 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79362207 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79243288 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.79095447 |
| 113 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.77532213 |
| 114 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.77068313 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76203470 |
| 116 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.76104788 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.75771376 |
| 118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75723640 |
| 119 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.74251440 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73339094 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.72046514 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.71997741 |
| 123 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.67464318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 5.97316678 |
| 2 | MP0005671_abnormal_response_to | 5.07472806 |
| 3 | MP0000685_abnormal_immune_system | 3.69514341 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.44783597 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.18616425 |
| 6 | * MP0000703_abnormal_thymus_morphology | 3.12658901 |
| 7 | * MP0002398_abnormal_bone_marrow | 3.02159711 |
| 8 | * MP0001800_abnormal_humoral_immune | 3.02137196 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.99515415 |
| 10 | MP0009785_altered_susceptibility_to | 2.87998170 |
| 11 | MP0002006_tumorigenesis | 2.87913985 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.86118040 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.85130769 |
| 14 | * MP0001819_abnormal_immune_cell | 2.81359950 |
| 15 | MP0001790_abnormal_immune_system | 2.79084664 |
| 16 | MP0005387_immune_system_phenotype | 2.79084664 |
| 17 | * MP0002723_abnormal_immune_serum | 2.72082231 |
| 18 | MP0006082_CNS_inflammation | 2.66100915 |
| 19 | MP0002405_respiratory_system_inflammati | 2.61606524 |
| 20 | * MP0000716_abnormal_immune_system | 2.56148702 |
| 21 | * MP0002722_abnormal_immune_system | 2.51118147 |
| 22 | MP0005025_abnormal_response_to | 2.42015530 |
| 23 | * MP0002452_abnormal_antigen_presenting | 2.41565329 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.36679517 |
| 25 | MP0001873_stomach_inflammation | 2.36157350 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.29272610 |
| 27 | MP0004947_skin_inflammation | 2.27140439 |
| 28 | MP0002396_abnormal_hematopoietic_system | 2.25260265 |
| 29 | MP0002933_joint_inflammation | 2.22135575 |
| 30 | MP0003724_increased_susceptibility_to | 2.12305514 |
| 31 | * MP0002429_abnormal_blood_cell | 2.09242202 |
| 32 | MP0003866_abnormal_defecation | 2.04697708 |
| 33 | MP0003436_decreased_susceptibility_to | 2.01725753 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.85354761 |
| 35 | MP0004381_abnormal_hair_follicle | 1.82836103 |
| 36 | MP0002132_abnormal_respiratory_system | 1.77585840 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.75598167 |
| 38 | MP0002419_abnormal_innate_immunity | 1.64034401 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.62958607 |
| 40 | MP0000858_altered_metastatic_potential | 1.59877475 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.54236189 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.51871878 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.42306578 |
| 44 | MP0001853_heart_inflammation | 1.33433128 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.33169039 |
| 46 | MP0005310_abnormal_salivary_gland | 1.30569480 |
| 47 | MP0008057_abnormal_DNA_replication | 1.30261712 |
| 48 | MP0002019_abnormal_tumor_incidence | 1.28347793 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.28268207 |
| 50 | MP0000490_abnormal_crypts_of | 1.24629126 |
| 51 | MP0002009_preneoplasia | 1.24355357 |
| 52 | MP0003448_altered_tumor_morphology | 1.21759009 |
| 53 | MP0004510_myositis | 1.17421734 |
| 54 | MP0003077_abnormal_cell_cycle | 1.16363274 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.14757908 |
| 56 | MP0004957_abnormal_blastocyst_morpholog | 1.03573346 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.03193620 |
| 58 | MP0008469_abnormal_protein_level | 1.01700179 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.01299448 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.01299448 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.01087815 |
| 62 | MP0001851_eye_inflammation | 0.94780630 |
| 63 | MP0001919_abnormal_reproductive_system | 0.93147485 |
| 64 | MP0000569_abnormal_digit_pigmentation | 0.90187130 |
| 65 | MP0003111_abnormal_nucleus_morphology | 0.90156219 |
| 66 | MP0003303_peritoneal_inflammation | 0.85873817 |
| 67 | MP0008058_abnormal_DNA_repair | 0.85388523 |
| 68 | MP0001533_abnormal_skeleton_physiology | 0.84122663 |
| 69 | MP0003172_abnormal_lysosome_physiology | 0.80716739 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.80354828 |
| 71 | MP0008007_abnormal_cellular_replicative | 0.80142983 |
| 72 | MP0005408_hypopigmentation | 0.79692849 |
| 73 | MP0009278_abnormal_bone_marrow | 0.79333523 |
| 74 | MP0001243_abnormal_dermal_layer | 0.76205739 |
| 75 | MP0005023_abnormal_wound_healing | 0.74554206 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.71115775 |
| 77 | MP0000371_diluted_coat_color | 0.69102949 |
| 78 | MP0005166_decreased_susceptibility_to | 0.68728142 |
| 79 | MP0002095_abnormal_skin_pigmentation | 0.67729191 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.66518588 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.64958494 |
| 82 | MP0009763_increased_sensitivity_to | 0.62719892 |
| 83 | MP0000477_abnormal_intestine_morphology | 0.62036750 |
| 84 | MP0003252_abnormal_bile_duct | 0.62003695 |
| 85 | MP0003045_fibrosis | 0.60700480 |
| 86 | MP0002254_reproductive_system_inflammat | 0.60190233 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.59491736 |
| 88 | MP0003786_premature_aging | 0.58463338 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.57825321 |
| 90 | MP0000313_abnormal_cell_death | 0.57782255 |
| 91 | MP0004130_abnormal_muscle_cell | 0.56993125 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.55713784 |
| 93 | MP0001191_abnormal_skin_condition | 0.54115369 |
| 94 | MP0000350_abnormal_cell_proliferation | 0.50403486 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.49774069 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.49083196 |
| 97 | MP0000604_amyloidosis | 0.48619566 |
| 98 | MP0000609_abnormal_liver_physiology | 0.48474401 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.47609868 |
| 100 | MP0003878_abnormal_ear_physiology | 0.47609868 |
| 101 | MP0005409_darkened_coat_color | 0.47559929 |
| 102 | MP0003795_abnormal_bone_structure | 0.47114535 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.46852532 |
| 104 | MP0002163_abnormal_gland_morphology | 0.46522010 |
| 105 | MP0005390_skeleton_phenotype | 0.46132962 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.45894003 |
| 107 | MP0001730_embryonic_growth_arrest | 0.44505864 |
| 108 | MP0002083_premature_death | 0.42709339 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.42198930 |
| 110 | MP0000367_abnormal_coat/_hair | 0.42110241 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.42055945 |
| 112 | MP0004883_abnormal_blood_vessel | 0.41556566 |
| 113 | MP0001663_abnormal_digestive_system | 0.40542055 |
| 114 | MP0008873_increased_physiological_sensi | 0.39318667 |
| 115 | MP0009764_decreased_sensitivity_to | 0.38600356 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.38308757 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.38151010 |
| 118 | MP0002822_catalepsy | 0.36616019 |
| 119 | MP0008770_decreased_survivor_rate | 0.36590672 |
| 120 | MP0010307_abnormal_tumor_latency | 0.36205983 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.35409508 |
| 122 | MP0008872_abnormal_physiological_respon | 0.34482184 |
| 123 | MP0001119_abnormal_female_reproductive | 0.34131833 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.34064563 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.33780509 |
| 126 | MP0000249_abnormal_blood_vessel | 0.33491564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.79852544 |
| 2 | Abnormality of T cell number (HP:0011839) | 9.41548473 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 7.74468904 |
| 4 | Combined immunodeficiency (HP:0005387) | 7.19726901 |
| 5 | Abnormality of T cells (HP:0002843) | 6.18903658 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 5.64100176 |
| 7 | Abnormality of B cell number (HP:0010975) | 5.61247440 |
| 8 | B lymphocytopenia (HP:0010976) | 5.61247440 |
| 9 | Thyroiditis (HP:0100646) | 5.56248053 |
| 10 | IgG deficiency (HP:0004315) | 5.19625355 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.17293814 |
| 12 | Hypoplasia of the thymus (HP:0000778) | 5.06232116 |
| 13 | Abnormality of eosinophils (HP:0001879) | 4.93937873 |
| 14 | Recurrent viral infections (HP:0004429) | 4.92417202 |
| 15 | Eosinophilia (HP:0001880) | 4.85421075 |
| 16 | Recurrent bronchitis (HP:0002837) | 4.81641610 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.69369932 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 4.31596500 |
| 19 | Stomatitis (HP:0010280) | 4.25549427 |
| 20 | Granulocytopenia (HP:0001913) | 4.16489011 |
| 21 | IgM deficiency (HP:0002850) | 4.15564780 |
| 22 | Leukocytosis (HP:0001974) | 3.99389458 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.86960466 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.86960466 |
| 25 | Nasal polyposis (HP:0100582) | 3.86292584 |
| 26 | Increased IgM level (HP:0003496) | 3.83499317 |
| 27 | Chronic otitis media (HP:0000389) | 3.75450072 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.56849671 |
| 29 | Myositis (HP:0100614) | 3.45260224 |
| 30 | Lymphopenia (HP:0001888) | 3.42328009 |
| 31 | Aplastic anemia (HP:0001915) | 3.39804561 |
| 32 | Chronic diarrhea (HP:0002028) | 3.39525910 |
| 33 | Abnormality of the fingertips (HP:0001211) | 3.38657096 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.35120539 |
| 35 | Pustule (HP:0200039) | 3.33609631 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.31062909 |
| 37 | Eczematoid dermatitis (HP:0000976) | 3.30865164 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27835102 |
| 39 | Joint swelling (HP:0001386) | 3.24484664 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 3.21086895 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 3.15230323 |
| 42 | Lymphoma (HP:0002665) | 2.96758504 |
| 43 | Meningitis (HP:0001287) | 2.93035373 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.87013336 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.86862392 |
| 46 | Bronchitis (HP:0012387) | 2.73546634 |
| 47 | Hypoproteinemia (HP:0003075) | 2.68402556 |
| 48 | Basal cell carcinoma (HP:0002671) | 2.62329781 |
| 49 | Encephalitis (HP:0002383) | 2.56431178 |
| 50 | Optic neuritis (HP:0100653) | 2.54316847 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.54316847 |
| 52 | IgA deficiency (HP:0002720) | 2.51315462 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.50251875 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.47529052 |
| 55 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.45111795 |
| 56 | Vasculitis (HP:0002633) | 2.41227206 |
| 57 | Hemoptysis (HP:0002105) | 2.40123379 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.35183915 |
| 59 | Agammaglobulinemia (HP:0004432) | 2.33497175 |
| 60 | Recurrent otitis media (HP:0000403) | 2.27568720 |
| 61 | Stomach cancer (HP:0012126) | 2.25767190 |
| 62 | Verrucae (HP:0200043) | 2.22898033 |
| 63 | Papilloma (HP:0012740) | 2.22898033 |
| 64 | Orchitis (HP:0100796) | 2.20415629 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.18291203 |
| 66 | Recurrent skin infections (HP:0001581) | 2.15222536 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.12960711 |
| 68 | Hypochromic anemia (HP:0001931) | 2.10294158 |
| 69 | Recurrent abscess formation (HP:0002722) | 2.10116277 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.09715413 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.09695215 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.09512632 |
| 73 | Anorexia (HP:0002039) | 2.07715814 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.06690226 |
| 75 | Acute hepatic failure (HP:0006554) | 2.06308868 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06146477 |
| 77 | Thrombocytosis (HP:0001894) | 2.05334322 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.05283653 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03541301 |
| 80 | Obstructive lung disease (HP:0006536) | 2.03541301 |
| 81 | Chronic sinusitis (HP:0011109) | 2.01460794 |
| 82 | Urticaria (HP:0001025) | 1.95226489 |
| 83 | Restrictive lung disease (HP:0002091) | 1.92691644 |
| 84 | Cellular immunodeficiency (HP:0005374) | 1.92161019 |
| 85 | Bronchiectasis (HP:0002110) | 1.91346063 |
| 86 | Increased IgE level (HP:0003212) | 1.90202873 |
| 87 | Abnormality of the prostate (HP:0008775) | 1.89707104 |
| 88 | Skin rash (HP:0000988) | 1.89406941 |
| 89 | Abnormality of the thymus (HP:0000777) | 1.89251007 |
| 90 | Keratoconjunctivitis (HP:0001096) | 1.89044044 |
| 91 | Pulmonary fibrosis (HP:0002206) | 1.86993629 |
| 92 | Hemiplegia (HP:0002301) | 1.85424860 |
| 93 | Ureteral stenosis (HP:0000071) | 1.79844016 |
| 94 | Poikiloderma (HP:0001029) | 1.79453828 |
| 95 | Amaurosis fugax (HP:0100576) | 1.77647889 |
| 96 | Prostate neoplasm (HP:0100787) | 1.77017842 |
| 97 | Neutropenia (HP:0001875) | 1.76340445 |
| 98 | Trigonocephaly (HP:0000243) | 1.76227938 |
| 99 | Recurrent pneumonia (HP:0006532) | 1.75854102 |
| 100 | Colitis (HP:0002583) | 1.73718919 |
| 101 | Arthralgia (HP:0002829) | 1.72423819 |
| 102 | Cheilitis (HP:0100825) | 1.71085043 |
| 103 | Abnormality of the peritoneum (HP:0002585) | 1.70570777 |
| 104 | Epistaxis (HP:0000421) | 1.70454437 |
| 105 | Arterial thrombosis (HP:0004420) | 1.70385066 |
| 106 | Glomerulopathy (HP:0100820) | 1.69617912 |
| 107 | Keratitis (HP:0000491) | 1.68081473 |
| 108 | Bicuspid aortic valve (HP:0001647) | 1.67792896 |
| 109 | Pancytopenia (HP:0001876) | 1.67013602 |
| 110 | Pulmonary embolism (HP:0002204) | 1.64031567 |
| 111 | Abnormality of oral frenula (HP:0000190) | 1.63845643 |
| 112 | Abnormal platelet volume (HP:0011876) | 1.60947089 |
| 113 | Ureteral obstruction (HP:0006000) | 1.59281685 |
| 114 | Gangrene (HP:0100758) | 1.56821742 |
| 115 | Skin ulcer (HP:0200042) | 1.56468305 |
| 116 | Amyotrophic lateral sclerosis (HP:0007354) | 1.56203816 |
| 117 | Chest pain (HP:0100749) | 1.55916329 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.55497696 |
| 119 | Hepatitis (HP:0012115) | 1.53249783 |
| 120 | Entropion (HP:0000621) | 1.52543375 |
| 121 | Dislocated radial head (HP:0003083) | 1.50884948 |
| 122 | Sepsis (HP:0100806) | 1.50410441 |
| 123 | Muscle fiber atrophy (HP:0100295) | 1.50036935 |
| 124 | Prominent nose (HP:0000448) | 1.49150857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.62058177 |
| 2 | MAP4K1 | 5.89980894 |
| 3 | ZAP70 | 3.80468640 |
| 4 | ITK | 3.36489838 |
| 5 | JAK3 | 2.85577621 |
| 6 | FGFR4 | 2.71605374 |
| 7 | STK10 | 2.64818543 |
| 8 | IKBKE | 2.45457299 |
| 9 | NLK | 2.44299585 |
| 10 | GRK6 | 2.43703039 |
| 11 | RIPK4 | 2.40044630 |
| 12 | TESK2 | 2.39217342 |
| 13 | TYK2 | 2.35524002 |
| 14 | TAOK3 | 2.25455300 |
| 15 | KDR | 2.21942362 |
| 16 | MST4 | 2.16527770 |
| 17 | * LCK | 1.91329382 |
| 18 | JAK1 | 1.74331847 |
| 19 | FGFR3 | 1.72799796 |
| 20 | NME2 | 1.61584080 |
| 21 | MAP3K14 | 1.57467398 |
| 22 | TEC | 1.53097688 |
| 23 | MAP3K10 | 1.52106685 |
| 24 | EEF2K | 1.48433112 |
| 25 | TBK1 | 1.44846600 |
| 26 | HCK | 1.40855770 |
| 27 | BTK | 1.38819273 |
| 28 | CLK1 | 1.27617237 |
| 29 | PRPF4B | 1.26798245 |
| 30 | * SYK | 1.25794406 |
| 31 | BLK | 1.21298536 |
| 32 | PRKCQ | 1.19963166 |
| 33 | PRKCH | 1.16046212 |
| 34 | LRRK2 | 1.08678029 |
| 35 | CAMKK2 | 1.03884308 |
| 36 | CDC7 | 1.03637940 |
| 37 | CAMKK1 | 0.94526347 |
| 38 | PKN2 | 0.94452574 |
| 39 | MAP3K11 | 0.92870151 |
| 40 | TNK2 | 0.88569959 |
| 41 | IRAK4 | 0.88405755 |
| 42 | PDGFRB | 0.87954647 |
| 43 | MARK3 | 0.87674288 |
| 44 | MAP3K12 | 0.85848064 |
| 45 | SIK2 | 0.85105695 |
| 46 | MAP3K7 | 0.84740065 |
| 47 | LYN | 0.78571445 |
| 48 | PIM1 | 0.78231824 |
| 49 | RPS6KA4 | 0.76210306 |
| 50 | KIT | 0.75297250 |
| 51 | CDK12 | 0.74606704 |
| 52 | IKBKB | 0.74556200 |
| 53 | STK4 | 0.73185512 |
| 54 | MAP3K13 | 0.71804923 |
| 55 | CDK4 | 0.71105303 |
| 56 | JAK2 | 0.70221323 |
| 57 | ARAF | 0.69696799 |
| 58 | * CSK | 0.67332156 |
| 59 | MAP3K9 | 0.66469027 |
| 60 | TESK1 | 0.65147356 |
| 61 | ERN1 | 0.64200964 |
| 62 | MAP4K2 | 0.63918532 |
| 63 | ADRBK2 | 0.61674023 |
| 64 | TYRO3 | 0.61175662 |
| 65 | FES | 0.59585016 |
| 66 | PASK | 0.58430849 |
| 67 | BRD4 | 0.55626080 |
| 68 | NEK2 | 0.55499999 |
| 69 | SIK3 | 0.54909176 |
| 70 | TSSK6 | 0.54305844 |
| 71 | CHUK | 0.54133780 |
| 72 | FGFR1 | 0.53926207 |
| 73 | TRIB3 | 0.53027593 |
| 74 | GRK7 | 0.52439839 |
| 75 | NUAK1 | 0.51498027 |
| 76 | MAP2K2 | 0.51297639 |
| 77 | ZAK | 0.51190647 |
| 78 | BUB1 | 0.50991692 |
| 79 | MAPK7 | 0.50063291 |
| 80 | CSF1R | 0.48835291 |
| 81 | MARK2 | 0.48481353 |
| 82 | SCYL2 | 0.47519363 |
| 83 | MAPK11 | 0.45496051 |
| 84 | MAP3K1 | 0.43311705 |
| 85 | KSR2 | 0.42690359 |
| 86 | MELK | 0.42635408 |
| 87 | FGR | 0.41885899 |
| 88 | TGFBR2 | 0.41571170 |
| 89 | SMG1 | 0.41075145 |
| 90 | TLK1 | 0.40826286 |
| 91 | MAP2K3 | 0.40335640 |
| 92 | FGFR2 | 0.39110642 |
| 93 | * INSR | 0.38920405 |
| 94 | SRPK1 | 0.38852258 |
| 95 | RPS6KB2 | 0.38403789 |
| 96 | ALK | 0.37938334 |
| 97 | EPHB1 | 0.36705650 |
| 98 | HIPK2 | 0.36116644 |
| 99 | ACVR1B | 0.36069989 |
| 100 | * FYN | 0.35908582 |
| 101 | ATR | 0.35664401 |
| 102 | FLT3 | 0.35573727 |
| 103 | MUSK | 0.34973383 |
| 104 | TGFBR1 | 0.34499021 |
| 105 | CDK9 | 0.34048760 |
| 106 | MAP2K6 | 0.33869342 |
| 107 | PDK1 | 0.33471367 |
| 108 | IGF1R | 0.32450048 |
| 109 | MAPKAPK2 | 0.30733327 |
| 110 | RAF1 | 0.30274298 |
| 111 | MAP3K8 | 0.29176008 |
| 112 | CDK6 | 0.29129460 |
| 113 | VRK1 | 0.28548814 |
| 114 | MAPK4 | 0.27869009 |
| 115 | EPHA3 | 0.27631987 |
| 116 | PRKCI | 0.26679358 |
| 117 | EIF2AK1 | 0.26343367 |
| 118 | BCKDK | 0.25751009 |
| 119 | MAPK12 | 0.24496415 |
| 120 | MAP3K3 | 0.23806795 |
| 121 | VRK2 | 0.23703113 |
| 122 | IRAK1 | 0.23485137 |
| 123 | TAOK1 | 0.23044449 |
| 124 | WNK4 | 0.22991788 |
| 125 | ILK | 0.22919046 |
| 126 | CHEK1 | 0.22904717 |
| 127 | PIK3CG | 0.22635136 |
| 128 | AURKB | 0.22381071 |
| 129 | PRKD2 | 0.22333557 |
| 130 | CDK19 | 0.21594017 |
| 131 | TTN | 0.21497920 |
| 132 | BMPR2 | 0.21467764 |
| 133 | CSNK1A1L | 0.21194753 |
| 134 | TAOK2 | 0.19560001 |
| 135 | RPS6KA5 | 0.19441164 |
| 136 | PIK3CA | 0.19273970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 6.46104001 |
| 2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.07024382 |
| 3 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.16392778 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10466384 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.95391504 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.91333096 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.83542099 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.77906951 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.47655066 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.44694042 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.11917923 |
| 12 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07004820 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86447639 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75249436 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59437869 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.56866846 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56808703 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54392025 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51583940 |
| 20 | Ribosome_Homo sapiens_hsa03010 | 1.46229527 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40834480 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40788841 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.36841176 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32381986 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.31227924 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31068488 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30820737 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28569325 |
| 29 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27912576 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23188100 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19257328 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.15526674 |
| 33 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.12865447 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09881864 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09797196 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.07949266 |
| 37 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06824705 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.01993150 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00922347 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99242063 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 0.94595159 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.94477292 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91543121 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90395051 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89351141 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88498808 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.85753402 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.85312240 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85091791 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 0.84879835 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83906740 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81641589 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78046726 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76039996 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75478579 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74136113 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72207863 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.71201737 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.70497128 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69492618 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66991101 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.66459775 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.66068023 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.65519859 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.63193388 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.63160395 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61179291 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60198097 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59883500 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.54963705 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54511291 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52162062 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.51752914 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51292895 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50345354 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49682422 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49272955 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47220922 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46990959 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45090042 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.43961799 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43748877 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42022242 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41423881 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41055881 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40733946 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.37940119 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.37255876 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.37071407 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36562642 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36551484 |
| 92 | RNA polymerase_Homo sapiens_hsa03020 | 0.36019656 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35171527 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35011455 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.33029501 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32546585 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31606073 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28912064 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26262179 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25747506 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.23893779 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22429011 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21692178 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21406320 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20929028 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19578218 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.18896810 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17792212 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17291928 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17272096 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.16688244 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16133622 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15980952 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15338659 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.15063158 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14889328 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.14119819 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.12578746 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.10174931 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08435110 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.07763739 |

